In this issue, I had the chance to speak with Brian Klepper, Principal, Worksite Health Advisors, a company finding and vetting health care companies that consistently deliver measurably better health outcomes at far lower costs than conventional approaches. In this interview, Klepper explains the benefits of using high-performing organizations, domestically and internationally and healthcare innovation in the United States.
This issue also brings you news on a COVID-19 product exchange for healthcare providers and suppliers, the new insulin price cap, reimbursement on telehealth use and more.
Amid the COVID-19 pandemic, the medical travel industry worldwide will certainly feel the impact. Restricted travel options could cripple some programs, although when the bans are lifted, it will be back to business as usual. We at USDMT wish all of our readers good health and safety during this time of uncertainty. We are interested in hearing your perspectives on the pandemic and vision for the future which can be sent directly to: editor@USDomesticMedicalTravel.com.
Thank you for your interest in this exciting, growing market space
Editor and Publisher